Collectively, these findings enhance our understanding of the role of FOLH1/PSMA in prostate cancer biology and its potential as a multifaceted molecular indicator to inform prognosis and therapeutic strategies in prostate cancer. The gene discussed is FOLH1; the disease is prostate carcinoma.